Circulating miRNA and cell-free DNA as a potential diagnostic tool in early detection of biliary tract cancer: a meta-analysis

References

• Ahn, J.C., et al., 2021. Detection of circulating tumor cells and their implications as a biomarker for diagnosis, prognostication, and therapeutic monitoring in hepatocellular carcinoma. Hepatology (baltimore, Md.), 73 (1), 422–436.
   PubMed Web of Science ®Google Scholar
• Cote, G.A., et al., 2014. A pilot study to develop a diagnostic test for pancreatic ductal adenocarcinoma based on differential expression of select miRNA in plasma and bile. The american journal of gastroenterology, 109 (12), 1942–1952.
   PubMed Web of Science ®Google Scholar
• Cristiano, S., et al., 2019. Genome-wide cell-free DNA fragmentation in patients with cancer. Nature, 570 (7761), 385–389.
   PubMed Web of Science ®Google Scholar
• Dai, J., et al., 2020. Association of microRNA-27a rs895819 polymorphism with the risk of cancer: An updated meta-analysis. Gene, 728, 144185.
   PubMed Web of Science ®Google Scholar
• D'Avola, D., et al., 2018. High-density single-cell mRNA sequencing to characterize circulating tumor cells in hepatocellular carcinoma. Scientific reports, 8 (1), 11570.
   PubMedGoogle Scholar
• Filipów, S., and Łaczmański, Ł., 2019. Blood circulating miRNAs as cancer biomarkers for diagnosis and surgical treatment response. Frontiers in genetics, 10, 169.
   PubMed Web of Science ®Google Scholar
• Hennedige, T.P., Neo, W.T., and Venkatesh, S.K., 2014. Imaging of malignancies of the biliary tract-an update. Cancer imaging, 14 (1), 1–21.
   PubMedGoogle Scholar
• Huang, D., et al., 2021. Association between gallstones and the risk of biliary tract cancer: a systematic review and meta-analysis. Epidemiology and health, 43, e2021011.
   PubMed Web of Science ®Google Scholar
• Kirstein, M.M., and Vogel, A., 2016. Epidemiology and risk factors of cholangiocarcinoma. Visceral medicine, 32 (6), 395–400.
   PubMed Web of Science ®Google Scholar
• Kojima, M., et al., 2015. MicroRNA markers for the diagnosis of pancreatic and biliary tract cancers. PloS one, 10 (2), e0118220.
   PubMed Web of Science ®Google Scholar
• Lagos-Quintana, M., et al., 2001. Identification of novel genes coding for small expressed RNAs. Science (new york, N.Y.), 294 (5543), 853–858.
   PubMed Web of Science ®Google Scholar
• Lamarca, A., et al., 2019. 18F-fluorodeoxyglucose positron emission tomography (18FDG-PET) for patients with biliary tract cancer: Systematic review and meta-analysis. Journal of hepatology, 71 (1), 115–129.
   PubMed Web of Science ®Google Scholar
• Liu, C.H., et al., 2018. Circulating microRNA-21 as a prognostic, biological marker in cholangiocarcinoma. Journal of cancer research and therapeutics, 14 (1), 220.
   PubMed Web of Science ®Google Scholar
• Lv, X., Zhang, Z., and Yuan, W., 2021. Pretreatment prognostic nutritional index (PNI) as a prognostic factor in patients with biliary tract cancer: a meta-analysis. Nutrition and cancer, 73 (10), 1872–1881.
   PubMed Web of Science ®Google Scholar
• Macias, R.I., et al., 2019. Diagnostic and prognostic biomarkers in cholangiocarcinoma. Liver international, 39 (S1), 108–122.
   PubMedGoogle Scholar
• Marcano-Bonilla, L., et al., 2016. Biliary tract cancers: epidemiology, molecular pathogenesis, and genetic risk associations. Chinese clinical oncology, 5 (5), 61–61.
   PubMed Web of Science ®Google Scholar
• Tariq, N.-U.-A., McNamara, M.G., and Valle, J.W., 2019. Biliary tract cancers: current knowledge, clinical candidates, and future challenges. Cancer management and research, 11, 2623–2642.
   PubMed Web of Science ®Google Scholar
• Page, M.J., et al., 2021. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ, (372), n71.
   Google Scholar
• Rashid, A., 2002. Cellular and molecular biology of biliary tract cancers. Surgical oncology clinics of North america, 11 (4), 995–1009.
   PubMedGoogle Scholar
• Reduzzi, C., et al., 2020. A novel circulating tumor cell subpopulation for treatment monitoring and molecular characterization in biliary tract cancer. International journal of cancer, 146 (12), 3495–3503.
   PubMed Web of Science ®Google Scholar
• RevMan 2020. [Computer program]. Version 5.4. The Cochrane Collaboration.
   Google Scholar
• Rizzo, A., et al., 2020. Anti-EGFR monoclonal antibodies in advanced biliary tract cancer: a systematic review and meta-analysis. In vivo (Athens, Greece), 34 (2), 479–488.
   PubMed Web of Science ®Google Scholar
• Romero, D., 2019. Liquid outperforms tissue. Nature reviews. Clinical oncology, 16 (11), 660–660.
   Web of Science ®Google Scholar
• Schwartz, A. 2002–2006. Electronic source. Retrieved from http://araw.mede.uic.edu/cgi-bin/testcalc.pl.
   Google Scholar
• Shen, N., et al., 2019. Bile cell-free DNA as a novel and powerful liquid biopsy for detecting somatic variants in biliary tract cancer. Oncology reports, 42 (2), 549–560.
   PubMed Web of Science ®Google Scholar
• Suurmond, R., van Rhee, H., and Hak, T., 2017. Introduction, comparison, and validation of Meta‐Essentials: a free and simple tool for meta‐analysis. Research synthesis methods, 8 (4), 537–553.
   PubMed Web of Science ®Google Scholar
• Torre, L.A., et al., 2018. Worldwide burden of and trends in mortality from gallbladder and other biliary tract cancers. Clinical gastroenterology and hepatology : the official clinical practice journal of the american gastroenterological association, 16 (3), 427–437.
   PubMed Web of Science ®Google Scholar
• Whiting, P.F., QUADAS-2 Group*., et al., 2011. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Annals of internal medicine, 155 (8), 529–536.
   PubMed Web of Science ®Google Scholar
• Zamora, J., et al., 2006. Meta-DiSc: a software for meta-analysis of test accuracy data. BMC medical research methodology, 6 (1), 1–12.
   PubMedGoogle Scholar
• Zhong, Y., Wu, X., and Li, Q., 2019. Long noncoding RNAs as potential biomarkers and therapeutic targets in gallbladder cancer: a systematic review and meta-analysis. Cancer cell int, 19, 169.
   PubMed Web of Science ®Google Scholar
• Zhu, Y., et al., 2020. Diagnostic performance of various liquid biopsy methods in detecting colorectal cancer: a meta‐analysis. Cancer medicine, 9 (16), 5699–5707.
   PubMed Web of Science ®Google Scholar